Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AGIO

Agios Pharmaceuticals (AGIO)

Agios Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AGIO
DateTimeSourceHeadlineSymbolCompany
07/18/20247:00AMGlobeNewswire Inc.Agios to Webcast Conference Call of Second Quarter 2024 Financial Results on August 1, 2024NASDAQ:AGIOAgios Pharmaceuticals Inc
06/17/20245:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
06/17/20245:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
06/17/20245:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
06/17/20245:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
06/17/20245:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
06/17/20245:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
06/15/20248:45AMGlobeNewswire Inc.Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid CongressNASDAQ:AGIOAgios Pharmaceuticals Inc
06/07/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
06/06/20249:00AMGlobeNewswire Inc.Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ETNASDAQ:AGIOAgios Pharmaceuticals Inc
06/05/20247:50PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
06/05/20244:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
06/03/20246:30AMGlobeNewswire Inc.Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-ThalassemiaNASDAQ:AGIOAgios Pharmaceuticals Inc
05/30/20244:05PMGlobeNewswire Inc.Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024NASDAQ:AGIOAgios Pharmaceuticals Inc
05/28/20247:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGIOAgios Pharmaceuticals Inc
05/28/20247:00AMGlobeNewswire Inc.Agios Announces $905 Million Purchase Agreement for Vorasidenib RoyaltyNASDAQ:AGIOAgios Pharmaceuticals Inc
05/14/202410:00AMGlobeNewswire Inc.Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid CongressNASDAQ:AGIOAgios Pharmaceuticals Inc
05/06/20247:00AMGlobeNewswire Inc.Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024NASDAQ:AGIOAgios Pharmaceuticals Inc
05/03/20247:00AMGlobeNewswire Inc.Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024NASDAQ:AGIOAgios Pharmaceuticals Inc
05/02/20247:00AMGlobeNewswire Inc.Agios Reports Business Highlights and First Quarter 2024 Financial ResultsNASDAQ:AGIOAgios Pharmaceuticals Inc
04/18/20247:00AMGlobeNewswire Inc.Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024NASDAQ:AGIOAgios Pharmaceuticals Inc
04/09/20247:00AMGlobeNewswire Inc.Agios Publishes 2024 Environmental, Social and Governance (ESG) ReportNASDAQ:AGIOAgios Pharmaceuticals Inc
03/07/20246:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
03/05/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
03/05/20244:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
03/05/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
03/05/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
03/05/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
03/05/20247:00AMGlobeNewswire Inc.Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024NASDAQ:AGIOAgios Pharmaceuticals Inc
03/01/20244:27PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:AGIO

Your Recent History

Delayed Upgrade Clock